Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2014 | 1 |
2017 | 2 |
2018 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25.
N Engl J Med. 2018.
PMID: 30280641
Clinical Trial.
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, Iyer S, Reisman A, Wilner KD, Tursi J, Blackhall F; PROFILE 1014 Investigators.
Solomon BJ, et al.
N Engl J Med. 2014 Dec 4;371(23):2167-77. doi: 10.1056/NEJMoa1408440.
N Engl J Med. 2014.
PMID: 25470694
Free article.
Clinical Trial.
Item in Clipboard
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators.
Machiels JP, et al.
Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29.
Lancet Oncol. 2024.
PMID: 38561010
Clinical Trial.
Item in Clipboard
Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practice.
Molina-Vega M, García-Alemán J, Sebastián-Ochoa A, Mancha-Doblas I, Trigo-Pérez JM, Tinahones-Madueño F.
Molina-Vega M, et al. Among authors: trigo perez jm.
Endocrine. 2018 Feb;59(2):395-401. doi: 10.1007/s12020-017-1499-7. Epub 2017 Dec 23.
Endocrine. 2018.
PMID: 29275532
Item in Clipboard
Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases.
Sartor O, Heinrich D, Mariados N, Méndez Vidal MJ, Keizman D, Thellenberg Karlsson C, Peer A, Procopio G, Frank SJ, Pulkkanen K, Rosenbaum E, Severi S, Trigo Perez JM, Wagner V, Li R, Nordquist LT.
Sartor O, et al. Among authors: trigo perez jm.
Ann Oncol. 2017 Oct 1;28(10):2464-2471. doi: 10.1093/annonc/mdx331.
Ann Oncol. 2017.
PMID: 28961839
Free PMC article.
Clinical Trial.
Item in Clipboard
SEOM clinical guidelines for the treatment of non-small-cell lung cancer: an updated edition.
Trigo Pérez JM, Garrido López P, Felip Font E, Isla Casado D; SEOM (Spanish Society for Medical Oncology).
Trigo Pérez JM, et al.
Clin Transl Oncol. 2010 Nov;12(11):735-41. doi: 10.1007/s12094-010-0588-3.
Clin Transl Oncol. 2010.
PMID: 20974565
Item in Clipboard
Cite
Cite